Hsiri Therapeutics
Media, PA
- UEI
- FPJHXLEQDS19
- CAGE
- 6RXX2
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1400 N Providence Rd #115s, Media, PA 19063, USA
- Website
- hsiritherapeutics.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Structural modification of daptomycin to allow anti-pseudomonas activity | National Institutes of Health | $202,150 |
Quick answers
Is Hsiri Therapeutics registered in SAM.gov?
Yes. Hsiri Therapeutics's SAM.gov registration is active through February 28, 2027.
What is Hsiri Therapeutics's most recent federal award?
Hsiri Therapeutics's most recent federal grant award is Structural modification of daptomycin to allow anti-pseudomonas activity (R43AI124764), from National Institutes of Health, on August 1, 2016.
On GovTribe
See Hsiri Therapeutics's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors